Collplant Biotechnologies Ltd ADR (CLGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 249 | 98 | 299 | 43 | 10,184 |
| Cost of Goods | 536 | 545 | 773 | 278 | 615 |
| Gross Profit | -287 | -447 | -474 | -235 | 9,569 |
| Operating Expenses | 4,655 | 4,427 | 5,367 | 4,645 | 4,507 |
| Operating Income | -4,406 | -4,329 | -5,068 | -4,602 | 5,677 |
| Other Income | 196 | 134 | 379 | 225 | 85 |
| Pre-tax Income | -4,210 | -4,195 | -4,689 | -4,377 | 5,762 |
| Net Income Continuous | -4,210 | -4,195 | -4,689 | -4,377 | 5,762 |
| Net Income | $-4,210 | $-4,195 | $-4,689 | $-4,377 | $5,762 |
| EPS Basic Total Ops | -0.37 | -0.37 | -0.42 | -0.38 | 0.51 |
| EPS Basic Continuous Ops | -0.37 | -0.37 | -0.41 | -0.38 | 0.51 |
| EPS Diluted Total Ops | -0.37 | -0.37 | -0.40 | -0.38 | 0.49 |
| EPS Diluted Continuous Ops | -0.37 | -0.37 | -0.39 | -0.38 | 0.49 |
| EPS Diluted Before Non-Recurring Items | -0.37 | -0.37 | -0.42 | N/A | N/A |
| EBITDA(a) | $-4,145 | $-4,049 | $-4,784 | $-4,330 | $5,943 |